SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-058208
Filing Date
2024-05-13
Accepted
2024-05-13 08:01:24
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-20240331.htm   iXBRL 10-Q 1192870
2 EX-31.1 vrca-ex31_1.htm EX-31.1 13457
3 EX-31.2 vrca-ex31_2.htm EX-31.2 13699
4 EX-32.1 vrca-ex32_1.htm EX-32.1 11610
  Complete submission text file 0000950170-24-058208.txt   6008612

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vrca-20240331.xsd EX-101.SCH 1180587
66 EXTRACTED XBRL INSTANCE DOCUMENT vrca-20240331_htm.xml XML 832535
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 24936948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)